NCT00245895View on ClinicalTrials.gov

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 30, 2003

Study Completion Date

February 28, 2005

Conditions
Prostate CancerAnemia
Interventions
DRUG

Aranesp

Aranesp

Trial Locations (2)

97239

Oregon Health and Sciences University, Portland

98109

Seattle Cancer Care Alliance, Seattle

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
lead

University of Washington

OTHER

collaborator

Amgen

INDUSTRY

NCT00245895 - Study of Aranesp to Treat Anemia in Prostate Cancer Patients. | Biotech Hunter | Biotech Hunter